How to buy Natus Medical Incorporated stock - 20 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Natus Medical Incorporated stock

Own Natus Medical Incorporated stock in just a few minutes.

Natus Medical Incorporated is a medical devices business based in the US. Natus Medical Incorporated shares (NTUS) are listed on the NASDAQ and all prices are listed in US Dollars. Natus Medical Incorporated employs 1,420 staff and has a trailing 12-month revenue of around USD0.00.

How to buy shares in Natus Medical Incorporated

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Natus Medical Incorporated. Find the stock by name or ticker symbol: NTUS. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Natus Medical Incorporated reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Natus Medical Incorporated, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Natus Medical Incorporated. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Natus Medical Incorporated share price

Use our graph to track the performance of NTUS stocks over time.

Natus Medical Incorporated shares at a glance

Information last updated 2021-04-16.
52-week rangeUSD$16.38 - USD$28.83
50-day moving average USD$25.89
200-day moving average USD$22.66
Wall St. target priceUSD$36.00
PE ratio 65.2813
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.29

Buy Natus Medical Incorporated shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Natus Medical Incorporated stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Natus Medical Incorporated under- or over-valued?

Valuing Natus Medical Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Natus Medical Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Natus Medical Incorporated's P/E ratio

Natus Medical Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 65x. In other words, Natus Medical Incorporated shares trade at around 65x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Natus Medical Incorporated's EBITDA

Natus Medical Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$18.2 million.

The EBITDA is a measure of a Natus Medical Incorporated's overall financial performance and is widely used to measure a its profitability.

Natus Medical Incorporated financials

Revenue TTM USD$415.7 million
Gross profit TTM USD$236.2 million
Return on assets TTM -0.99%
Return on equity TTM -4.02%
Profit margin -4%
Book value $12.40
Market capitalisation USD$947.1 million

TTM: trailing 12 months

Shorting Natus Medical Incorporated shares

There are currently 867,081 Natus Medical Incorporated shares held short by investors – that's known as Natus Medical Incorporated's "short interest". This figure is 6.2% up from 816,298 last month.

There are a few different ways that this level of interest in shorting Natus Medical Incorporated shares can be evaluated.

Natus Medical Incorporated's "short interest ratio" (SIR)

Natus Medical Incorporated's "short interest ratio" (SIR) is the quantity of Natus Medical Incorporated shares currently shorted divided by the average quantity of Natus Medical Incorporated shares traded daily (recently around 166746.34615385). Natus Medical Incorporated's SIR currently stands at 5.2. In other words for every 100,000 Natus Medical Incorporated shares traded daily on the market, roughly 5200 shares are currently held short.

However Natus Medical Incorporated's short interest can also be evaluated against the total number of Natus Medical Incorporated shares, or, against the total number of tradable Natus Medical Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Natus Medical Incorporated's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Natus Medical Incorporated shares in existence, roughly 30 shares are currently held short) or 0.0307% of the tradable shares (for every 100,000 tradable Natus Medical Incorporated shares, roughly 31 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Natus Medical Incorporated.

Find out more about how you can short Natus Medical Incorporated stock.

Natus Medical Incorporated share dividends

We're not expecting Natus Medical Incorporated to pay a dividend over the next 12 months.

Natus Medical Incorporated share price volatility

Over the last 12 months, Natus Medical Incorporated's shares have ranged in value from as little as $16.38 up to $28.83. A popular way to gauge a stock's volatility is its "beta".

NTUS.US volatility(beta: 0.54)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Natus Medical Incorporated's is 0.5372. This would suggest that Natus Medical Incorporated's shares are less volatile than average (for this exchange).

Natus Medical Incorporated overview

Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site